Top Abstract Purchase Related
Home
>
Node
>
Subnode

Long-term prognosis of hepatocellular carcinoma patients treated with adoptive immunotherapy

Takeda, T.; Watanabe, M.; Umeshita, K.; Goto, M.; Monden, M.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1646-1648

2004

ISSN/ISBN: 0385-0684
PMID: 15553671
Document Number: 575556
Adoptive immunotherapy was performed for patients with multiple hepatocellular carcinoma (HCC) using LAK cells via the hepatic arterial catheter. One case study: A 45-year-old male patient was performed an absolute-non-cure operation. The operation was a success. However, some residual tumors remained in the liver. After the operation, adoptive immunotherapy was performed for 7 times in 5 weeks. The total inoculated LAK cells were 6.9x10(9). After the adoptive immunotherapy, no residual tumors were detected in the liver. He survived for 7 years in remission. Our results show that adoptive immunotherapy with LAK cells is useful and effective for patients with multiple HCC.

Document emailed within 1 workday
Secure & encrypted payments

Sasaki, Y.; Imaoka, S.; Masutani, S.; Ohashi, I.; Ishikawa, O.; Koyama, H.; Iwanaga, T. 1992: Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma Surgery 112(3): 515-521
Mamada, Y.; Tajiri, T.; Akimaru, K.; Yoshida, H.; Taniai, N. 2004: Long-term prognosis after arterio-portal embolization for hepatocellular carcinoma Hepato-Gastroenterology 51(55): 234-236
Kakisaka, T.; Kamiyama, T.; Yokoo, H.; Orimo, T.; Wakayama, K.; Tsuruga, Y.; Kamachi, H.; Hatanaka, K.; Taketomi, A. 2013: Long-term survival of a patient with metachronous lymph node metastasis and bile duct tumor thrombus due to hepatocellular carcinoma successfully treated with repeated surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1831-1833
Khuhaprema, T. 1999: Resection of hepatocellular carcinoma: personal experience with 67 patients and long-term results Journal of the Medical Association of Thailand 82(11): 1071-1078
Hashimoto, T.; Nakamura, H.; Tomoda, K.; Murakami, T.; Nakanishi, K.; Tsuda, K.; Ishida, T.; Kim, T.; Narumi, Y. 1997: Hepatocellular carcinoma patients showing long-term complete responses to chemoembolization Seminars in Oncology 24(2 Suppl 6: S6
Lundgren, J.D.; Phillips, A.N.; Pedersen, C.; Clumeck, N.; Gatell, J.M.; Johnson, A.M.; Ledergerber, B.; Vella, S.; Nielsen, J.O. 1994: Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group JAMA 271(14): 1088-1092
Oda, K.; Oguma, N.; Kawano, M.; Kimura, A.; Kuramoto, A.; Tokumo, K. 1987: Hepatocellular carcinoma associated with long-term anabolic steroid therapy in two patients with aplastic anemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(1): 29-36
Kamei, K.; Okada, M.; Miyazono, A.; Sato, M.; Fujimaru, T.; Ogura, M.; Ito, S. 2013: Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab Nihon Jinzo Gakkai Shi 55(5): 947-955
Battaglini, G.; Previtera, C.; Messineo, A.; Talenti, T.; Zancan, L. 1991: Long-term prognosis of patients with extrahepatic biliary atresia successfully treated with surgery. our experience Minerva Pediatrica 43(7-8): 493-498
Kitade, H.; Yanagida, H.; Yokoigawa, N.; Yamada, M.; Hijikawa, T.; Kaibori, M.; Matsui, K.; Ishizaki, M.; Yoshioka, K.; Kon, M. 2015: Two Patients with Recurrence of Hepatocellular Carcinoma after Liver Resection Who Achieved Long-Term Stable Disease with Small Doses of Sorafenib Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(7): 863-865
Kamiyoshihara, M.; Hirai, T.; Kawashima, O.; Sakata, S.; Morishita, Y. 1998: Analyses on the long-term prognosis of surgical treatment for primary lung cancer in the elderly patients of 75 or over years old: how should be treated the non-recurrent death? Kyobu Geka. Japanese Journal of Thoracic Surgery 51(2): 112-115
Ito, Y.; Higashiyama, T.; Takamura, Y.; Miya, A.; Kobayashi, K.; Matsuzuka, F.; Kuma, K.; Miyauchi, A. 2007: Long-term follow-up for patients with papillary thyroid carcinoma treated as benign nodules Anticancer Research 27(2): 1039-1043
Salup, R.R.; Toth, J.A.; Hiserodt, J.C.; Wolmark, N. 1987: Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes Progress in Clinical and Biological Research 244: 39-48
Iozzino, M.; Spaziani, E.; Picchio, M.; Saltarelli, A.; Di Filippo, A.; De Angelis, F.; Narilli, F.; Stagnitti, F.; Cianni, R. 2011: Long-term survival after transarterial chemoembolization for hepatocellular carcinoma La Clinica Terapeutica 162(2): 129-132
Negrier, S.; Maral, J.; Drevon, M.; Vinke, J.; Escudier, B.; Philip, T. 2000: Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe Cancer Journal from Scientific American 6(Suppl): S93-S98
Yamasaki, S.; Kosuge, T.; Yamamoto, J.; Shimada, K. 1998: Long-term results after hepatectomy for hepatocellular carcinoma according to cancer stage Nihon Geka Gakkai Zasshi 99(4): 219-222
Sauvanet, A. 2000: Hepatectomy for hepatocellular carcinoma: the role of the surgeon in long-term survival Annales de Chirurgie 125(1): 91-93
Okusaka, T.; Okada, S.; Ishii, H.; Nose, H.; Nagahama, H.; Nakasuka, H.; Ikeda, K.; Yoshimori, M. 1997: Prognosis of hepatocellular carcinoma patients with extrahepatic metastases Hepato-Gastroenterology 44(13): 251-257
Masutani, S.; Shimizu, J.; Tatsuta, M.; Masuda, F.; Imamura, H.; Ishida, H.; Furukawa, H.; Tomotsu, K.; Yura, M.; Obana, T.; Kitamura, S.; Saeki, N.; Inoue, Y.; Takamura, M.; Ohnishi, H. 2003: Long-term outcome of advanced hepatocellular carcinoma that received transarterial hepatic chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1579-1582
Yoshida, S.; Takai, N.; Saito, T.; Tanaka, R. 1987: Adoptive immunotherapy in patients with malignant glioma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1930-1932